Exosome Diagnostics is developing and commercializing revolutionary, biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.
Our novel exosome-based platform yields comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored.
Johan Skog, Ph.D., chief scientific officer of Exosome Diagnostics, will present at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain (Nov. 18–21, 2014).
Download PDF for details on his talk and our poster sessions at the meeting.
Play the below videos to learn more about the promise of exosomes in clinical practice.
Our new website will launch in mid-November 2014. Please come back and visit us then, or contact us in the interim.
Copyright © 2008–2014 Exosome Diagnostics, Inc. All rights reserved.